pubmed-article:15023378 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15023378 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:15023378 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:15023378 | lifeskim:mentions | umls-concept:C0409959 | lld:lifeskim |
pubmed-article:15023378 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
pubmed-article:15023378 | lifeskim:mentions | umls-concept:C0008466 | lld:lifeskim |
pubmed-article:15023378 | lifeskim:mentions | umls-concept:C0205267 | lld:lifeskim |
pubmed-article:15023378 | lifeskim:mentions | umls-concept:C1696465 | lld:lifeskim |
pubmed-article:15023378 | lifeskim:mentions | umls-concept:C1096776 | lld:lifeskim |
pubmed-article:15023378 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:15023378 | pubmed:dateCreated | 2004-3-16 | lld:pubmed |
pubmed-article:15023378 | pubmed:abstractText | To investigate the efficacy and tolerability of a 3-month duration, twice a-year, intermittent treatment with oral chondroitin sulfate (CS) in knee osteoarthritis (OA) patients. | lld:pubmed |
pubmed-article:15023378 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023378 | pubmed:language | eng | lld:pubmed |
pubmed-article:15023378 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023378 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15023378 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023378 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023378 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023378 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023378 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15023378 | pubmed:month | Apr | lld:pubmed |
pubmed-article:15023378 | pubmed:issn | 1063-4584 | lld:pubmed |
pubmed-article:15023378 | pubmed:author | pubmed-author:MarcolongoRob... | lld:pubmed |
pubmed-article:15023378 | pubmed:author | pubmed-author:VignonEricE | lld:pubmed |
pubmed-article:15023378 | pubmed:author | pubmed-author:MalaiseMichel... | lld:pubmed |
pubmed-article:15023378 | pubmed:author | pubmed-author:FioravantiAnt... | lld:pubmed |
pubmed-article:15023378 | pubmed:author | pubmed-author:UebelhartDani... | lld:pubmed |
pubmed-article:15023378 | pubmed:author | pubmed-author:PipernoMuriel... | lld:pubmed |
pubmed-article:15023378 | pubmed:author | pubmed-author:de... | lld:pubmed |
pubmed-article:15023378 | pubmed:author | pubmed-author:DeVathaireFlo... | lld:pubmed |
pubmed-article:15023378 | pubmed:author | pubmed-author:MailleuxElisa... | lld:pubmed |
pubmed-article:15023378 | pubmed:author | pubmed-author:MatosoLuisL | lld:pubmed |
pubmed-article:15023378 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15023378 | pubmed:volume | 12 | lld:pubmed |
pubmed-article:15023378 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15023378 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15023378 | pubmed:pagination | 269-76 | lld:pubmed |
pubmed-article:15023378 | pubmed:dateRevised | 2007-10-4 | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:meshHeading | pubmed-meshheading:15023378... | lld:pubmed |
pubmed-article:15023378 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15023378 | pubmed:articleTitle | Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. | lld:pubmed |
pubmed-article:15023378 | pubmed:affiliation | Department of Rheumatology, Institute of Physical Medicine, University Hospital Zurich, Switzerland. daniel.uebelhart@usz.ch | lld:pubmed |
pubmed-article:15023378 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15023378 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15023378 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:15023378 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:15023378 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15023378 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15023378 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15023378 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15023378 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15023378 | lld:pubmed |